Astrazeneca Treasury Limited

Active02910116 Private limited company
Incorporated
18 March 1994 (32 years)
Industry
Activities of head offices (70100)
Accounts type
Full
Region
East of England
Address
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge
CB2 0AA

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
1 April 2027
Last conf. stmt
18 March 2026

Officers 4 active

Officer details are public data from the Companies House register.

Johnstone, Camilla
Secretary · Appointed 1 May 2025
Director · Appointed 22 April 2025
British
Born December 1977 (48)
Director · Appointed 20 June 2018
British
Born November 1965
Director · Appointed 31 May 2017
British
Born December 1970 (55)
Officer history (18 former)
1 May 2025
Resigned Kemp, Adrian Charles Noel as Director
1 May 2025
Appointed Johnstone, Camilla as Secretary
1 May 2025
Resigned Bowden, Matthew Shaun as Secretary
22 April 2025
Appointed Bowden, Matthew Shaun as Director
27 February 2019
Appointed Bowden, Matthew Shaun as Secretary
27 February 2019
Resigned Jackson-Turner, Katie Louise as Secretary
20 June 2018
Appointed Slade, Jonathan Thomas Charles as Director
31 December 2017
Resigned Boucher, Brendan James as Director
31 May 2017
Resigned Brimicombe, Ian Martin David as Director
31 May 2017
Appointed Collins, Iain Alistair as Director
31 July 2015
Resigned O'Grady, Claire-Marie as Secretary
15 July 2015
Appointed Jackson-Turner, Katie Louise as Secretary
17 November 2014
Resigned Darlington, Keith Stuart as Director
4 November 2014
Appointed Kemp, Adrian Charles Noel as Director
4 November 2014
Appointed O'Grady, Claire-Marie as Secretary
4 November 2014
Resigned Kemp, Adrian Charles Noel as Secretary
17 October 2014
Resigned Greenfield, Patricia May as Director
22 September 2014
Appointed Boucher, Brendan James as Director
23 February 2011
Appointed Darlington, Keith Stuart as Director
23 February 2011
Appointed Greenfield, Patricia May as Director
23 February 2011
Resigned Christie, Sean Lloyd as Director
18 March 2010
Resigned Cole, John Howard as Director
1 January 2009
Appointed Kemp, Adrian Charles Noel as Secretary
31 December 2008
Resigned Musker, Graeme Harold Rankine as Secretary
31 July 2007
Resigned Symonds, Jonathan Richard as Director
11 September 2006
Appointed Christie, Sean Lloyd as Director
11 September 2006
Resigned Marsh, Adrian Ross Thomas as Director
11 September 2006
Appointed Brimicombe, Ian Martin David as Director
30 June 2003
Appointed Marsh, Adrian Ross Thomas as Director
25 July 2002
Resigned Nordberg, Per Alf Gunner as Director
29 August 2000
Resigned Juniper, Jane Fiona as Director
29 August 2000
Appointed Symonds, Jonathan Richard as Director
29 August 2000
Appointed Cole, John Howard as Director
29 August 2000
Appointed Nordberg, Per Alf Gunner as Director
29 August 2000
Resigned Lachlan, Cacilia Maria as Nominee Director
25 August 2000
Appointed Musker, Graeme Harold Rankine as Secretary
25 August 2000
Resigned Lachlan, Cacilia Maria as Nominee Secretary
18 March 1994
Appointed Juniper, Jane Fiona as Director
18 March 1994
Appointed Lachlan, Cacilia Maria as Nominee Director
18 March 1994
Appointed Lachlan, Cacilia Maria as Nominee Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 3674842

Holdings 8

Companies where Astrazeneca Treasury Limited is registered as a person with significant control

Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Dissolved
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active

Group structure 19 shown

Ownership group derived from the Companies House PSC register

Astrazeneca UK Limited Owns 75–100% of shares
Alderley Park Ventures Limited Has significant influence or control
Astrazeneca China UK Limited DissolvedOwns 75–100% of shares
Astrazeneca Finance Limited DissolvedOwns 75–100% of shares
Astrazeneca Investments Limited In liquidationOwns 75–100% of shares
Astrazeneca Japan Limited In liquidationOwns 75–100% of shares
Astrazeneca Nominees Limited Owns 75–100% of shares
Astrazeneca Quest Limited Owns 75–100% of shares
Astrazeneca Share Trust Limited Owns 75–100% of shares
Astrazeneca Treasury Limited This company Owns 75–100% of shares
British Pharma Group Limited Holds 25–50% of voting rights
Evinova Limited Owns 75–100% of shares
Kudos Pharmaceuticals Limited Owns 75–100% of shares
Medimmune U.K. Limited Owns 75–100% of shares
Astrazeneca US Investments Limited DissolvedOwns 75–100% of shares

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
29 June 2026Full accounts31 December 202540
18 March 2026Confirmation statement with no updates18 March 20263
3 July 2025Full accounts31 December 202442
1 May 2025Termination of appointment of a secretary1
1 May 2025Termination of appointment of a director1
Show all recent filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Cambridge →

Explore the largest companies

Largest companies in Cambridge, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?